|
|
Article: New genetics & genomics study findings reported from A. Degrandi and co-authors.
- Article from:
- Biotech Week
- Article date:
- November 11, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
"A genetic marker screening panel, ParkScreen, optimized for simultaneous marker amplification, was constructed to test or exclude linkage in families with parkinsonism or Parkinson's disease, using only a few affected individuals per family. ParkScreen functionality was proven by detection of linkage to PARK2 in a family with known Parkin mutations, exclusion of linkage to several of the known loci, and detection of suggestive linkage to PARK8, PARK3, and PARK11 in some families," investigators in Bolzano, Italy report (see also Genetics & Genomics).
"In a novel approach, we also tested the ability of ParkScreen to screen patients originating from isolated ...
Related newspaper, magazine, and journal articles:
|
|
Article: Research on molecular neuroscience described by ...
Health & Medicine Week;
March 23, 2009 ;
700+ words
... ... research published in the Journal of Molecular Neuroscience, Many ion channels show low basal ... Medical Department (see also Molecular Neuroscience). The researchers concluded ... published their study in the Journal of Molecular Neuroscience (Amplitude Histogram-Based Method ...
|
|